Table 2.
The crude and age-standardized incidence rate (ASR) (per 1000 person-years) of hypertension by age and sex: Tehran Lipid and Glucose Study (1999–2018).
| Age categories, years | Total population | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|---|
| E/N | Crude | ASR | E/N | Crude | ASR | E/N | Crude | ASR | |
| – 20–29 | 279/1821 | 11.7(10.4–13.1) | 11.7(10.3–13.1) | 146/725 | 16.1(13.7–18.9) | 16.1(13.6–18.9) | 133/1096 | 8.9(7.6–10.6) | 8.9(7.5–10.6) |
| – 30–39 | 563/2083 | 21.2(19.5–23.0) | 21.2(19.5–23.0) | 269/913 | 23.7(21.1–26.8) | 23.7(21.0–26.8) | 294/1170 | 19.3(17.2–21.6) | 19.3(17.1–21.6) |
| – 40–49 | 578/1372 | 37.4(34.4–40.5) | 37.4(34.4–40.5) | 222/581 | 33.0(28.9–37.6) | 33.0(28.8–37.6) | 356/791 | 40.7(36.9–45.2) | 40.7(36.9–45.1) |
| – 50–59 | 432/775 | 57.0(51.9–62.6) | 57.0(51.7–62.6) | 186/361 | 49.9(43.2–57.6) | 49.9(43.0–57.6) | 246/414 | 63.8(56.3–72.3) | 63.8(56.1–72.3) |
| – ≥60 | 279/482 | 69.6(61.9–78.2) | 69.6(61.6–78.2) | 172/314 | 64.3(55.4–74.6) | 64.3(55.4–74.6) | 107/168 | 80.2(66.3–96.9) | 80.2(65.7–96.9) |
| Total | 2131/6533 | 27.5(26.3–28.7) | 36.1(34.3–38.0) | 995/2894 | 29.7(27.8–31.6) | 34.9(32.5–37.4) | 1136/3639 | 25.8(24.3–27.3) | 38.7(35.5–42.0) |
E/N: Event/Number; ASR: Age-standardized rates using Standard world (Segi’s) population.